Hola,
Are you new here?

I have an account

¿Te ayudamos?

Ejemplos de búsqueda

Vídeos Explicativos

RECOPHARMA

financed

Closed

Removal and Recovery of Pharmaceutical Persistent Pollutants from Wastewater by...

Removal and Recovery of Pharmaceutical Persistent Pollutants from Wastewater by Selective Reagentless Process Pharmaceutical drugs, characterized by their environmental persistence (e.g. cytostatic drugs [CDs]) have been detected in water bodies (drinking water, groundwater, surface water, and effluent wastewater) at concentrations up to... see more

31/10/2023

UAB

896K€

Project Budget: 896K€

Project leader

UNIVERSITAT AUTÒNOMA DE BARCELONA No se ha especificado una descripción o un objeto social para esta compañía.

total researchers 1271

PARTICIPATION DEPralty Sin fecha límite de participación.

Ver 8 Participantes

Financing granted El organismo H2020 notifico la concesión del proyecto The day 2023-10-31

MSCA-RISE-2017: Research and Innovation Staff Excha... Objective:The RISE scheme will promote international and inter-sector collaboration through research...

I+D

Cerrada does 8 years

0% 100% 100%

characteristics of the participant

Este proyecto no cuenta con búsquedas de partenariado abiertas en este momento.

Private Information

No hay información privada compartida para este proyecto. Habla con el coordinador.

8 Participantes

UAB

270.00K€ | Leader

AERIS TECNOLOGIAS AMBIENTALE...

63.00K€ | participant

EFB

67.50K€ | participant

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Project duration: 72 months Date Start: 2017-10-17
End date: 2023-10-31

Project leader

UNIVERSITAT AUTÒNOMA DE BARCELONA No se ha especificado una descripción o un objeto social para esta compañía.

total researchers 1271

Project Budget 896K€

participation deadline Sin fecha límite de participación.

Project description Pharmaceutical drugs, characterized by their environmental persistence (e.g. cytostatic drugs [CDs]) have been detected in water bodies (drinking water, groundwater, surface water, and effluent wastewater) at concentrations up to μg/L level. Actual methods for the removal and degradation of CDs, including electrochemical, photochemical, and biological methods have been developed. However, these methods are expensive and sometimes inefficient for CDs complete removal from the treated water. Including the exploitation of previous results from EU funded projects, the goal of project RECOPHARMA is to design, develop, validate and demonstrate a novel process by sequential integration the potentials offered by Molecular Imprinted Polymers (MIPs), Reagentless Thermosorption (RTS), Nanocomposites Functional Materials, Advanced Oxidation Processes, for an effective treatment aiming the recovery of target recalcitrant CDs and degradation of corresponding transformation products or metabolites, working in a continuous operation mode. The suggested approach offers versatile, fast, highly efficient, and low-cost treatment for wastewaters. RECOPHARMA brings together academic research centres and the private sector, with a long-term goal of designing and developing advanced water treatment technologies in the interest of the society and integrate them for demonstration following a circular economy approach. Through the scheduled secondments, the involved staff will perform the required R&I to demonstrate the technical and economic feasibility of the developed process, including the technical formation of specialists as a fundamental activity to project success. The secondments will also enhance the exchange of knowledge, best practices, know-how, innovations, experience, mutual cooperation and culture of work between different organizations, regions and countries through the partners’ well-established reputation as transfer hubs.

Conecta tu I+D

Entra hoy

Forgot your password?

Financing

Companies

CTIs/Universidades

Projects

researchers